A recent report published by Infinium Global Research on antacids
market provides in-depth analysis of segments and sub-segments in global as
well as regional antacids market. The study also highlights the impact of
drivers, restraints and macro indicators on the global and regional antacids
market over the short term as well as long term. The report is a comprehensive
presentation of trends, forecast and dollar values of global antacids market. According
to the report the global antacids market is projected to grow at a CAGR of 4% over
the forecast period of 2018-2024. It was worth USD 4.50 billion and it is
anticipated to surpass USD 9.0 billion by 2024.
An antacid is a substance that
neutralizes stomach acidity and it is used to relieve the body from indigestion
and upset stomach. When excessive amounts of acids are produced in the stomach
the natural mucous barrier that protects the stomach can damage the esophagus
with acid. Combination of aluminum-magnesium antacids are less likely to cause
constipation or diarrhea they are only aluminum or only magnesium antacids.
They can also be used to relieve the pain of the stomach and ulcers some antacids
contain simethicone which reduces gas. The report defines the antacid market as
drug classes such as Disease Modifying Anti-rheumatic Drugs, Nonsteroidal
Anti-inflammatory Drugs, Corticosteroids, and Uric Acid Drugs among Others sold
through the various distribution channels such as Hospital Pharmacy, Retail
Pharmacy, and Online Pharmacy. These antacids are served in the form of tablet,
liquid, and powder.
Increasing geriatric population
around the world is the major driving factor responsible for the growth of the
antacids market. According to data from World Population Prospects 2017, the
number of older persons those aged 60 years or over are 962 million globally in
2017 comprising about 13 %of the global population, which is expected to be more
than double accounting for nearly 1.5 billion by the end of 2030. Additionally,
the intake of medication for other medical conditions, which are associated
with acid reflux and excess acid production also accounts for significant
demand for antacids among this population. On the other hand, the rising
popularity of e-commerce and surge in the number of online medicine providers
are estimated to positively influence the expansion of the market. Moreover,
the restraints that are likely to hamper the growth in the antacids market
include side effects associated with these antacids such as constipation,
laxative effect, and allergic reactions.
North America is expected to be
the largest region for the antacid market followed by the Asia Pacific by 2024.
Currently, due to the drastic change in the dietary habits of people, North
America is the largest dominating region. Moreover, Asia Pacific is an emerging
market for antacid due to the increase in the aging population. China and India
are key domestic markets in the region due to the improvement of healthcare
services. The key players in the antacid market include Johnson & Johnson,
Pfizer Inc and Sanofi. Johnson & Johnson-Merck's Mylanta is the number one
antacid in the U.S. market following a 25% sales gain. Sanofi, the French
pharmaceutical company, has agreed to accept Johnson & Johnson's Rolaids
antacid medicine as part of its momentum into the growing consumer healthcare
market. Sanofi identified consumer healthcare as a core growth platform for the
company and subsequently acquired Chattanooga, Tennessee-based Chattem in March
2010. The acquisition of Chattem provided Sanofi with a presence in the U.S.
consumer healthcare market.
The report on global antacids market covers segments such as, by
drug class, by formulation and by distribution channel. On the basis of by drug
class, the global antacids market is categorized into proton pump inhibitor, H2 antagonist
and acid neutralizers. On the basis of formulation, the global antacids
market is categorized into tablet, liquid, and powder. On the basis of by
distribution channel, the global antacids market is categorized into hospital pharmacy,
retail pharmacy, and online pharmacy.
The report provides regional analysis covering geographies such as
North America, Europe, Asia-Pacific, and Rest of the World. In this section, the
key trends and market size for each geography is provided over the period of
The countries covered in the North America region include the U.S.,
Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South
Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and
Rest of Europe are included in the European region. The U.S. drives the growth
in the North America region as it is the largest market in the region. The
Asia-pacific region offers a substantial potential for the market growth owing
to rapid growth in markets such as India and China. The APAC region is
projected to experience growth at a CAGR of x.x% over the period of
The report provides profiles of the companies in the global
antacids market such as WellSpring Pharm, Private Lable, GSK, Johnson &
Johnson, Novartis Consumer Health, Boehringer Ingelheim Pharm,
GlaxoSmithKline, Procter & Gamble, Pfizer, and First Aid Only.
The report provides deep insights on demand forecasts, market
trends, and micro and macro indicators. In addition, this report provides
insights into the factors that are driving and restraining the global antacids market.
Moreover, IGR-Growth Matrix analysis given in the report brings an insight into
the investment areas that existing or new market players can consider. The
report provides insights into the market using analytical tools such as
Porter's five forces analysis and DRO analysis of antacids market. Moreover,
the study highlights current market trends and provides forecast from
2018-2024. We also have highlighted future trends in the antacids market that
will impact the demand during the forecast period. Moreover, the competitive
analysis given in each regional market brings an insight into the market share of
the leading players. This report will help manufacturers, suppliers, and
distributors of the antacids market to understand the present and future trends
in this market and formulate their strategies accordingly.